| Literature DB >> 30824323 |
Madelene W Dahlgren1, Stephen W Jones1, Kelly M Cautivo1, Alexandra Dubinin1, Jorge F Ortiz-Carpena1, Sepideh Farhat1, Kevin S Yu2, Katharine Lee2, Chaoqun Wang3, Anna V Molofsky4, Aaron D Tward2, Matthew F Krummel5, Tien Peng3, Ari B Molofsky6.
Abstract
Type 2 lymphocytes promote both physiologic tissue remodeling and allergic pathology, yet their physical tissue niches are poorly described. Here, we used quantitative imaging to define the tissue niches of group 2 innate lymphoid cells (ILC2s), which are critical instigators of type 2 immunity. We identified a dominant adventitial niche around lung bronchi and larger vessels in multiple tissues, where ILC2s localized with subsets of dendritic and regulatory T cells. However, ILC2s were most intimately associated with adventitial stromal cells (ASCs), a mesenchymal fibroblast-like subset that expresses interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP). In vitro, ASCs produced TSLP that supported ILC2 accumulation and activation. ILC2s and IL-13 drove reciprocal ASC expansion and IL-33 expression. During helminth infection, ASC depletion impaired lung ILC2 and Th2 cell accumulation and function, which are in part dependent on ASC-derived IL-33. These data indicate that adventitial niches are conserved sites where ASCs regulate type 2 lymphocyte expansion and function.Entities:
Keywords: 3D-imaging; IL-33; ILC2s; TSLP; Th2 cells; allergic asthma; group 2 innate lymphoid cells; mesenchymal cells; resident lymphocytes; stromal cells; tissue niches; type 2 immunity
Mesh:
Substances:
Year: 2019 PMID: 30824323 PMCID: PMC6553479 DOI: 10.1016/j.immuni.2019.02.002
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745